ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $396,000 | +51.7% | 20,985 | -5.3% | 0.08% | +45.5% |
| Q2 2019 | $261,000 | -7.1% | 22,154 | +158.1% | 0.06% | -59.6% |
| Q3 2016 | $281,000 | +31.3% | 8,582 | 0.0% | 0.14% | -14.5% |
| Q2 2016 | $214,000 | +20.2% | 8,582 | +18.0% | 0.16% | -35.1% |
| Q1 2016 | $178,000 | -30.2% | 7,273 | -5.9% | 0.24% | -65.0% |
| Q4 2015 | $255,000 | – | 7,728 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |